1 citations
,
April 2017 in “Journal of Investigative Dermatology” D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.
17 citations
,
December 2010 in “Journal of Investigative Dermatology” Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.
4 citations
,
February 2019 in “Revista da Associação Médica Brasileira” FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.
October 2015 in “Annals of Internal Medicine” Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.
4 citations
,
November 2020 in “Case reports in dermatology” A rare skin condition causes red, dark, bumpy facial lesions.
January 2016 in “Hair transplant forum international” The document corrects the definitions of terms related to FUE, a hair transplant technique.
4 citations
,
November 2013 in “Hair transplant forum international” The document calls for standardized terms and definitions in hair transplant methods.
179 citations
,
December 2004 in “Journal of The American Academy of Dermatology” Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.
October 2012 in “Sax's Dangerous Properties of Industrial Materials” December 2018 in “International journal of women’s dermatology” FFA in young women is often missed, and no single treatment works best.
2 citations
,
January 2015 in “Journal of Investigative Dermatology”
April 1999 in “Archives of Facial Plastic Surgery”
October 2023 in “Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy” New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.
9 citations
,
February 2012 in “Cancer Chemotherapy and Pharmacology” The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.
July 2024 in “Medical alphabet” Modern therapies, like fractional laser, effectively treat telogen effluvium.
1 citations
,
March 2013 in “The European Journal of Contraception & Reproductive Health Care” The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.
2 citations
,
January 2023 in “Dermatologic Therapy” CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.
60 citations
,
November 2009 in “General and Comparative Endocrinology” Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.
September 2021 in “CRC Press eBooks” Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.
May 2013 in “Facial Plastic Surgery Clinics of North America”
GV-350 improves hair growth and quality of life in iron-deficient women without side effects.
January 1976 in “Revista de Estudios Agrosociales” Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.
13 citations
,
December 2007 in “The Journal of Dermatology” Fexofenadine may help treat alopecia areata.
April 2018 in “Journal of Investigative Dermatology” Fetuin A, Anigozanthos Flavidus extract, and Ovol2 affect wound healing and skin regeneration.
1 citations
,
February 2025 in “Notulae Scientia Biologicae” Optimized emulgels with Levofloxacin effectively treat eye infections with prolonged drug release and safety.
4 citations
,
January 1996 in “PubMed” Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.
1 citations
,
April 2024 in “Pathogens” A pet ferret had a serious infection from Mycobacterium xenopi, which can spread to humans.
6 citations
,
May 2013 in “Journal of Clinical Oncology” Combining Ficlatuzumab and Gefitinib can cause severe hair loss.
January 2019 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”